Preparation of highly activated natural killer cells for advanced lung cancer therapy

Background: Natural killer (NK) cells can be used as an adoptive immunotherapy to treat cancer patients. Purpose: In this study, we evaluated the efficacy of highly activated NK (HANK) cell immunotherapy in patients with advanced lung cancer. Patients and methods: Between March 2016 and September 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Silun, Wu, Zhenyi, Niu, Lizhi, Chen, Jibing, Ma, Yunkun, Zhang, Mingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616273/
https://www.ncbi.nlm.nih.gov/pubmed/31308687
http://dx.doi.org/10.2147/OTT.S201924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616273/
https://www.ncbi.nlm.nih.gov/pubmed/31308687
http://dx.doi.org/10.2147/OTT.S201924

Ejemplares similares